GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Renata PLC (DHA:RENATA) » Definitions » EBITDA Margin %

Renata (DHA:RENATA) EBITDA Margin % : 16.77% (As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is Renata EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Renata's EBITDA for the three months ended in Mar. 2024 was BDT1,547 Mil. Renata's Revenue for the three months ended in Mar. 2024 was BDT9,226 Mil. Therefore, Renata's EBITDA margin for the quarter that ended in Mar. 2024 was 16.77%.


Renata EBITDA Margin % Historical Data

The historical data trend for Renata's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Renata EBITDA Margin % Chart

Renata Annual Data
Trend Dec13 Dec14 Dec15 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 26.85 28.31 26.40 24.87 13.43

Renata Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.07 -6.69 19.92 18.76 16.77

Competitive Comparison of Renata's EBITDA Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Renata's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Renata's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Renata's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Renata's EBITDA Margin % falls into.



Renata EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Renata's EBITDA Margin % for the fiscal year that ended in Jun. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Jun. 2023 )/Revenue (A: Jun. 2023 )
=4427.802/32970.756
=13.43 %

Renata's EBITDA Margin % for the quarter that ended in Mar. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=1547.014/9226.168
=16.77 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Renata  (DHA:RENATA) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Renata EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Renata's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Renata (DHA:RENATA) Business Description

Traded in Other Exchanges
N/A
Address
Plot Number 1, Milk Vita Road, Section-7, GPO Box No. 303, Mirpur, Dhaka, BGD, 1216
Renata Ltd is a Bangladesh based pharmaceutical company. It is engaged in the manufacturing, marketing, and distribution of Human Pharmaceuticals, Animal Health Medicines, Nutritionals, and Vaccines. It manufactures various pharmaceutical products including Beconex Zi Syrup, Cabolin Tablet, Flontin Tablet, Ivana Tablet, and others. Some of the animal health products offered by the company are Doxivet Powder, Fevenil Injection, Diadin Bolus, Renamet Tablet, and others. The company operates in Bangladesh and sells its products locally and internationally.

Renata (DHA:RENATA) Headlines

No Headlines